Tbx5 and Osr1 interact to regulate posterior second heart field cell cycle progression for cardiac septation

Journal of Molecular and Cellular Cardiology

Volumn 85, Issue , 2015, Pages 1-12

  Zhou, Lun ^a,b   Liu, Jielin ^a   Olson, Patrick ^a   Zhang, Ke ^a   Wynne, Joshua ^a   Xie, Linglin ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Atrioventricular septal defects (AVSDs); Cell cycle; Osr1; Pten; Second heart field; Tbx5

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMOOTHENED PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR TBX5; OSR1 PROTEIN, MOUSE; PTEN PROTEIN, MOUSE; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR 5; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; CARDIAC STEM CELL; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STRUCTURES; GENE; GENE EXPRESSION; GENE INTERACTION; GENE MUTATION; HAPLOINSUFFICIENCY; HEART ATRIUM SEPTUM; HEART DEVELOPMENT; HEDGEHOG SIGNALING PATHWAY; HOLT ORAM SYNDROME; MOUSE; MOUSE EMBRYO; NONHUMAN; ODD SKIPPED 1 GENE; PRIORITY JOURNAL; SECOND HEART FIELD; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; 129 MOUSE; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CELL CYCLE; EMBRYOLOGY; EMBRYONIC STEM CELL; EPISTASIS; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; HUMAN; INTERATRIAL SEPTUM; METABOLISM; TRANSGENIC MOUSE;

ERINACEIDAE;

ANIMALS; ATRIAL SEPTUM; CELL CYCLE; EMBRYONIC STEM CELLS; EPISTASIS, GENETIC; HEK293 CELLS; HUMANS; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; PTEN PHOSPHOHYDROLASE; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84929575332     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.05.005     Document Type: Article

References (51)

1. Kaplan S. Congenital heart disease in adolescents and adults. Natural and postoperative history across age groups. Cardiol Clin 1993, 11:543-556.
2. Malumbres M., Barbacid M. Mammalian cyclin-dependent kinases. Trends Biochem Sci 2005, 30:630-641.
3. Snarr B.S., Kern C.B., Wessels A. Origin and fate of cardiac mesenchyme. Dev Dyn 2008, 237:2804-2819.
4. Webb S., Brown N.A., Anderson R.H. Formation of the atrioventricular septal structures in the normal mouse. Circ Res 1998, 82:645-656.
5. Zhang X.M., Ramalho-Santos M., McMahon A.P. Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R asymmetry by the mouse node. Cell 2001, 105:781-792.
6. Lan Y., Liu H., Ovitt C.E., Jiang R. Generation of Osr1 conditional mutant mice. Genesis 2011, 49:419-422.
7. Wessels A., Anderson R.H., Markwald R.R., Webb S., Brown N.A., Viragh S., et al. Atrial development in the human heart: an immunohistochemical study with emphasis on the role of mesenchymal tissues. Anat Rec 2000, 259:288-300.
8. Anderson R.H., Webb S., Brown N.A., Lamers W., Moorman A. Development of the heart: (2) septation of the atriums and ventricles. Heart 2003, 89:949-958.
9. Galli D., Dominguez J.N., Zaffran S., Munk A., Brown N.A., Buckingham M.E. Atrial myocardium derives from the posterior region of the second heart field, which acquires left-right identity as Pitx2c is expressed. Development 2008, 135:1157-1167.
10. Goddeeris M.M., Rho S., Petiet A., Davenport C.L., Johnson G.A., Meyers E.N., et al. Intracardiac septation requires hedgehog-dependent cellular contributions from outside the heart. Development 2008, 135:1887-1895.
11. Hoffmann A.D., Peterson M.A., Friedland-Little J.M., Anderson S.A., Moskowitz I.P. Sonic hedgehog is required in pulmonary endoderm for atrial septation. Development 2009, 136:1761-1770.
12. Mommersteeg M.T., Soufan A.T., de Lange F.J., van den Hoff M.J., Anderson R.H., Christoffels V.M., et al. Two distinct pools of mesenchyme contribute to the development of the atrial septum. Circ Res 2006, 99:351-353.
13. Snarr B.S., O'Neal J.L., Chintalapudi M.R., Wirrig E.E., Phelps A.L., Kubalak S.W., et al. Isl1 expression at the venous pole identifies a novel role for the second heart field in cardiac development. Circ Res 2007, 101:971-974.
14. Tian Y., Cohen E.D., Morrisey E.E. The importance of Wnt signaling in cardiovascular development. Pediatr Cardiol 2010, 31:342-348.
15. Basson C.T., Bachinsky D.R., Lin R.C., Levi T., Elkins J.A., Soults J., et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997, 15:30-35.
16. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
17. Li Q.Y., Newbury-Ecob R.A., Terrett J.A., Wilson D.I., Curtis A.R., Yi C.H., et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 1997, 15:21-29.
18. Schott J.J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281:108-111.
19. Bruneau B.G., Logan M., Davis N., Levi T., Tabin C.J., Seidman J.G., et al. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol 1999, 211:100-108.
20. Hiroi Y., Kudoh S., Monzen K., Ikeda Y., Yazaki Y., Nagai R., et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 2001, 28:276-280.
21. Bruneau B.G. The developing heart and congenital heart defects: a make or break situation. Clin Genet 2003, 63:252-261.
22. Mori A.D., Zhu Y., Vahora I., Nieman B., Koshiba-Takeuchi K., Davidson L., et al. Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol 2006, 297:566-586.
23. Xie L., Hoffmann A.D., Burnicka-Turek O., Friedland-Little J.M., Zhang K., Moskowitz I.P. Tbx5-hedgehog molecular networks are essential in the second heart field for atrial septation. Dev Cell 2012, 23:280-291.
24. Coulter D.E., Swaykus E.A., Beran-Koehn M.A., Goldberg D., Wieschaus E., Schedl P. Molecular analysis of odd-skipped, a zinc finger encoding segmentation gene with a novel pair-rule expression pattern. EMBO J 1990, 9:3795-3804.
25. Wang Q., Lan Y., Cho E.S., Maltby K.M., Jiang R. Odd-skipped related 1 (Odd 1) is an essential regulator of heart and urogenital development. Dev Biol 2005, 288:582-594.
26. Hoffmann A.D., Yang X.H., Burnicka-Turek O., Bosman J.D., Ren X., Steimle J.D., et al. Foxf genes integrate tbx5 and hedgehog pathways in the second heart field for cardiac septation. PLoS Genet 2014, 10:e1004604.
27. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
28. Joyner A.L., Zervas M. Genetic inducible fate mapping in mouse: establishing genetic lineages and defining genetic neuroanatomy in the nervous system. Dev Dyn 2006, 235:2376-2385.
29. Mugford J.W., Sipila P., McMahon J.A., McMahon A.P. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol 2008, 324:88-98.
30. Hu Y.C., Okumura L.M., Page D.C. Gata4 is required for formation of the genital ridge in mice. PLoS Genet 2013, 9:e1003629.
31. Mugford J.W., Sipila P., Kobayashi A., Behringer R.R., McMahon A.P. Hoxd11 specifies a program of metanephric kidney development within the intermediate mesoderm of the mouse embryo. Dev Biol 2008, 319:396-405.
32. Watanabe Y., Zaffran S., Kuroiwa A., Higuchi H., Ogura T., Harvey R.P., et al. Fibroblast growth factor 10 gene regulation in the second heart field by Tbx1, Nkx2-5, and Islet1 reveals a genetic switch for down-regulation in the myocardium. Proc Natl Acad Sci U S A 2012, 109:18273-18280.
33. Kelly R.G. The second heart field. Curr Top Dev Biol 2012, 100:33-65.
34. Zhang Z., Cerrato F., Xu H., Vitelli F., Morishima M., Vincentz J., et al. Tbx1 expression in pharyngeal epithelia is necessary for pharyngeal arch artery development. Development 2005, 132:5307-5315.
35. Rana M.S., Theveniau-Ruissy M., De Bono C., Mesbah K., Francou A., Rammah M., et al. Tbx1 coordinates addition of posterior second heart field progenitor cells to the arterial and venous poles of the heart. Circ Res 2014, 115:790-799.
36. Liao J., Aggarwal V.S., Nowotschin S., Bondarev A., Lipner S., Morrow B.E. Identification of downstream genetic pathways of Tbx1 in the second heart field. Dev Biol 2008, 316:524-537.
37. Bruneau B.G., Nemer G., Schmitt J.P., Charron F., Robitaille L., Caron S., et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001, 106:709-721.
38. Crosio C., Fimia G.M., Loury R., Kimura M., Okano Y., Zhou H., et al. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol Cell Biol 2002, 22:874-885.
39. Songyang Z., Baltimore D., Cantley L.C., Kaplan D.R., Franke T.F. Interleukin 3-dependent survival by the Akt protein kinase. Proc Natl Acad Sci U S A 1997, 94:11345-11350.
40. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998, 95:29-39.
41. Di Cristofano A., Pandolfi P.P. The multiple roles of PTEN in tumor suppression. Cell 2000, 100:387-390.
42. Diao L., Chen Y.G. PTEN, a general negative regulator of cyclin D expression. Cell Res 2007, 17:291-292.
43. Huang W., Chang H.Y., Fei T., Wu H., Chen Y.G. GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene 2007, 26:2471-2482.
44. Ramaswamy S., Nakamura N., Vazquez F., Batt D.B., Perera S., Roberts T.M., et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 1999, 96:2110-2115.
45. McDermott D.A., Bressan M.C., He J., Lee J.S., Aftimos S., Brueckner M., et al. TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res 2005, 58:981-986.
46. Heinritz W., Shou L., Moschik A., Froster U.G. The human TBX5 gene mutation database. Hum Mutat 2005, 26:397.
47. Stirnimann C.U., Ptchelkine D., Grimm C., Muller C.W. Structural basis of TBX5-DNA recognition: the T-box domain in its DNA-bound and -unbound form. J Mol Biol 2010, 400:71-81.
48. Smith C.A., Kortemme T. Backrub-like backbone simulation recapitulates natural protein conformational variability and improves mutant side-chain prediction. J Mol Biol 2008, 380:742-756.
49. Briggs L.E., Kakarla J., Wessels A. The pathogenesis of atrial and atrioventricular septal defects with special emphasis on the role of the dorsal mesenchymal protrusion. Differentiation 2012, 84:117-130.
50. Briggs L.E., Phelps A.L., Brown E., Kakarla J., Anderson R.H., van den Hoff M.J., et al. Expression of the BMP receptor Alk3 in the second heart field is essential for development of the dorsal mesenchymal protrusion and atrioventricular septation. Circ Res 2013, 112:1420-1432.
51. Tian Y., Yuan L., Goss A.M., Wang T., Yang J., Lepore J.J., et al. Characterization and in vivo pharmacological rescue of a Wnt2-Gata6 pathway required for cardiac inflow tract development. Dev Cell 2010, 18:275-287.